NCT04337047

Brief Summary

There are many scales for screening or assessing the impact of a disease. These scales are generally used to diagnose or assess the severity of a disease and are carried out at the request of a physician by the patient. Conversational agents could make it possible to administer these questionnaires remotely, analyse them and use the results on a large scale, without prior medical intervention. The main objective of this study is to quantify and qualify the distress of a large population in times of pandemic crisis.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
2,000

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Mar 2020

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 31, 2020

Completed
3 days until next milestone

First Submitted

Initial submission to the registry

April 3, 2020

Completed
4 days until next milestone

First Posted

Study publicly available on registry

April 7, 2020

Completed
23 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 30, 2020

Completed
3 days until next milestone

Study Completion

Last participant's last visit for all outcomes

May 3, 2020

Completed
Last Updated

May 5, 2020

Status Verified

May 1, 2020

Enrollment Period

1 month

First QC Date

April 3, 2020

Last Update Submit

May 3, 2020

Conditions

Stress, Psychological

Outcome Measures

Primary Outcomes (1)

  • quantify and qualify distress over a large population in times of pandemic crisis.

    1 month

Secondary Outcomes (1)

  • qualify demographic data vs distress over a large population in times of pandemic crisis.

    1 month

Study Arms (4)

Vik sein

Vik sein users

Other: questionnaire assesment

Vik asthme

Vik asthme users

Other: questionnaire assesment

Vik migraine

Vik migraine users

Other: questionnaire assesment

Vik depression

Vik depression users

Other: questionnaire assesment

Interventions

questionnaire assesmentOTHER

questionnaire assesment

Vik asthmeVik depressionVik migraineVik sein

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Vik's users in France

You may qualify if:

  • Age \> 18 years old
  • Collection of the subject's non-opposition
  • Patient registration on Vik breast, Vik asthma, Vik migraine, Vik depression

You may not qualify if:

  • Patient unable to formulate non-opposition

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Wefight

Montpellier, 34000, France

Location

Related Publications (1)

  • Chaix B, Delamon G, Guillemasse A, Brouard B, Bibault JE. Psychological distress during the COVID-19 pandemic in France: a national assessment of at-risk populations. Gen Psychiatr. 2020 Nov 26;33(6):e100349. doi: 10.1136/gpsych-2020-100349. eCollection 2020.

    PMID: 34192239DERIVED

MeSH Terms

Conditions

Stress, Psychological

Condition Hierarchy (Ancestors)

Behavioral SymptomsBehavior

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
INDUSTRY
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Chief Science Officer

Study Record Dates

First Submitted

April 3, 2020

First Posted

April 7, 2020

Study Start

March 31, 2020

Primary Completion

April 30, 2020

Study Completion

May 3, 2020

Last Updated

May 5, 2020

Record last verified: 2020-05

Data Sharing

IPD Sharing
Will not share

Locations

FR(1)